Regli Adrian, De Keulenaer Bart, De Laet Inneke, Roberts Derek, Dabrowski Wojciech, Malbrain Manu L N G
Department of Intensive Care and High Care Burn Unit, Ziekenhuis Netwerk Antwerpen, Belgium.
Anaesthesiol Intensive Ther. 2015;47(1):45-53. doi: 10.5603/AIT.a2014.0067. Epub 2014 Nov 25.
Intra-abdominal hypertension (IAH) and abdominal compartment syndrome (ACS) are consistently associated with morbidity and mortality among the critically ill or injured. Thus, avoiding or potentially treating these conditions may improve patient outcomes. With the aim of improving the outcomes for patients with IAH/ACS, the World Society of the Abdominal Compartment Syndrome recently updated its clinical practice guidelines. In this article, we review the association between a positive fluid balance and outcomes among patients with IAH/ACS and how optimisation of fluid administration and systemic/regional perfusion may potentially lead to improved outcomes among this patient population.Evidence consistently associates secondary IAH with a positive fluid balance. However, despite increased research in the area of non-surgical management of patients with IAH and ACS, evidence supporting this approach is limited. Some evidence exists to support implementing goal-directed resuscitation protocols and restrictive fluid therapy protocols in shocked and recovering critically ill patients with IAH. Data from animal experiments and clinical trials has shown that the early use of vasopressors and inotropic agents is likely to be safe and may help reduce excessive fluid administration, especially in patients with IAH. Studies using furosemide and/or renal replacement therapy to achieve a negative fluid balance in patients with IAH are encouraging. The type of fluid to be administered in patients with IAH remains far from resolved. There is currently insufficient evidence to recommend the use of abdominal perfusion pressure as a resuscitation endpoint in patients with IAH. However, it is important to recognise that IAH either abolishes or increases threshold values for pulse pressure variation and stroke volume variation to predict fluid responsiveness, while the presence of IAH may also result in a false negative passive leg raising test.Correct fluid therapy and perfusional support during resuscitation form the cornerstone of medical management in patients with abdominal hypertension. Controlled studies determining whether the above medical interventions may improve outcomes among those with IAH/ACS are urgently required.
腹内高压(IAH)和腹腔间隔室综合征(ACS)一直与危重症或受伤患者的发病率和死亡率相关。因此,避免或潜在治疗这些病症可能会改善患者的预后。为了改善IAH/ACS患者的预后,世界腹腔间隔室综合征协会最近更新了其临床实践指南。在本文中,我们回顾了IAH/ACS患者中液体正平衡与预后之间的关联,以及液体管理和全身/局部灌注的优化如何可能改善该患者群体的预后。
证据一致表明继发性IAH与液体正平衡有关。然而,尽管对IAH和ACS患者的非手术管理领域的研究有所增加,但支持这种方法的证据有限。有一些证据支持在患有IAH的休克和恢复中的危重症患者中实施目标导向复苏方案和限制性液体治疗方案。动物实验和临床试验的数据表明,早期使用血管加压药和正性肌力药物可能是安全的,并且可能有助于减少过多的液体输注,特别是在IAH患者中。使用呋塞米和/或肾脏替代疗法使IAH患者达到液体负平衡的研究令人鼓舞。IAH患者应输注的液体类型仍远未解决。目前没有足够的证据推荐将腹腔灌注压作为IAH患者的复苏终点。然而,重要的是要认识到,IAH会消除或增加脉压变异和每搏量变异的阈值以预测液体反应性,而IAH的存在也可能导致被动抬腿试验出现假阴性结果。
复苏期间正确的液体治疗和灌注支持是腹内高压患者医疗管理的基石。迫切需要进行对照研究,以确定上述医疗干预措施是否可以改善IAH/ACS患者的预后。